WINALL(300087)
Search documents
荃银高科:2023半年度募集资金实际存放与使用情况的专项报告
2023-08-25 11:02
安徽荃银高科种业股份有限公司 2023 年半年度募集资金实际存放与使用情况专项报告 一、募集资金基本情况 (一)扣除发行费用后的实际募集资金金额、资金到账时间 根据中国证券监督管理委员会《关于同意安徽荃银高科种业股份有限公司向特定对象发行 股票注册的批复》(证监许可﹝2021﹞1815 号),公司于 2021 年 7 月向 6 名特定对象发行人 民币普通股(A 股)23,768,366 股。截至 2021 年 7 月 22 日止,公司实际发行人民币普通股(股) 23,768,366.00 股,每股面值 1 元,每股发行价格 23.14 元,实际募集资金总额 549,999,989.24 元,全额存入广发银行合肥蜀山支行的 9550880218643200269 银行账户。另扣除保荐承销费、 审计验资费、法律费等发行费用合计人民币 13,059,999.74 元(含增值税 739,245.27 元),手 续费 23,768.37 元,实际募集资金净额人民币 536,916,221.13 元。上述募集资金到位情况业经 大信会计师事务所(特殊普通合伙)验证,并出具了大信验字[2021]第 32-10001 号《验资 ...
荃银高科:关于向金融机构申请综合授信的公告
2023-08-25 11:02
本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假 记载、误导性陈述或重大遗漏。 安徽荃银高科种业股份有限公司(以下简称"公司"或"荃银高 科")于 2023 年 8 月 24 日召开第五届董事会第十三次会议,审议通 过《关于向金融机构申请综合授信的议案》。现将相关事项公告如下: 一、申请综合授信的主要内容 1、申请原因 荃银高科目前已成为拥有 24 家控股子公司的集团公司,随着业 务规模的不断扩大及业务量的持续增加,子公司随之增加相应的资金 需求。控股子公司新疆金丰源种业有限公司(以下简称"金丰源") 为满足生产经营的资金需求,进一步补充流动性同时发挥多家金融机 构比较优势,降低资金成本,拟向金融机构申请综合授信额度。 证券代码:300087 证券简称:荃银高科 公告编号:2023-045 安徽荃银高科种业股份有限公司 关于向金融机构申请综合授信的公告 2、申请额度 金丰源拟向金融机构申请综合授信 3.5 亿元,专用于籽棉收购。 3、授信品种 包括但不限于流动资金贷款、应收账款保理、票据承兑、票据贴 现、商票融资、开立保函、远期国内信用证及押汇、远期信用证及押 汇、进口代付、减免保证金外汇交 ...
荃银高科:证券投资、期货与衍生品交易管理制度
2023-08-25 11:02
证券投资、期货与衍生品交易管理制度 第一章 总则 第一条 为规范安徽荃银高科种业股份有限公司(以下简称"公司")的证 券投资、期货和衍生品交易业务,保障公司资金安全,有效控制风险,提高投资 收益,维护公司及全体股东利益,根据《中华人民共和国公司法》、《中华人民 共和国证券法》、《深圳证券交易所创业板股票上市规则》、《深圳证券交易所 上市公司自律监管指引第 2 号——创业板上市公司规范运作》、《深圳证券交易 所上市公司自律监管指引第 7 号——交易与关联交易》等法律、法规、规范性文 件及《安徽荃银高科种业股份有限公司章程》的有关规定,结合公司实际情况, 制定本制度。 安徽荃银高科种业股份有限公司 第二条 本制度适用于公司及控股子公司的证券投资、期货和衍生品交易。 控股子公司拟进行证券投资或期货、衍生品交易的,须报公司并根据本制度履行 相应的审批程序,未经审批不得进行证券投资或期货、衍生品交易。 第三条 本制度所称"证券投资",是指新股配售或者申购、证券回购、股 票及存托证投资、债券投资以及中国证监会、深圳证券交易所认定的其他投资行 为。 本制度所称"期货交易"是指以期货合约或者标准化期权合约为交易标的的 交易活 ...
荃银高科:关于开展期货和衍生品业务的可行性分析报告
2023-08-25 11:02
2、业务规模及业务期间 安徽荃银高科种业股份有限公司 关于开展期货和衍生品业务的可行性分析报告 一、开展期货和衍生品业务的目的 随着公司"走出去"战略的推进,海外业务日益壮大,日常经营中涉及进出 口业务的外汇体量逐渐增加。汇率波动对经营成本、出口收入、经营利润有直接 重要影响,根据不同外汇走势采取即期、远期结售汇等方式,有利于锁定出口收 益。为了有效对冲汇率波动风险,公司严格按照实际需求开展金融类衍生业务, 拟配合实际业务开展套保操作。同时,公司控股子公司新疆金丰源种业有限公司 (以下简称"金丰源")主营业务为主要农作物种子的研发、生产和销售以及棉 花的初加工与销售,为规避棉花价格大幅波动给经营带来的不利影响,保证经营 业绩相对稳定,金丰源通过棉花期货合约进行对冲操作,利用合理的金融工具锁 定成本,降低风险,提高公司竞争力。 公司及下属子公司拟开展的期货、衍生品交易业务是以套期保值、有效规避 市场风险为目的,与公司日常经营需求相匹配,不存在投机性操作。 二、期货和衍生品业务的基本情况 1、交易品种 (1)外汇衍生品:远期汇率锁定类期货和衍生品业务。 (2)商品套期保值的品种:仅限于境内商品期货交易所挂牌交易并 ...
荃银高科:关于中化集团财务有限责任公司2023年半年度风险评估报告
2023-08-25 11:02
中化集团财务有限责任公司系经中国银行保险监督管理委员会(现为国家金 融监督管理总局)批准,由中国中化集团有限公司(以下简称"中化集团")出 资,在北京成立的有限责任公司。公司于2008年6月4日在国家市场监督管理总局 办理了工商登记,企业法人营业执照注册号:100000000041669;法定代表人: 陈国钢;注册资本100,000万元;注册地:北京市西城区复兴门内大街28号凯晨 世贸中心中座F3层;总部地址:北京西城区。本公司于2022年10月26日变更营业 执照,法定代表人变更为李福利;注册资本:600,000万元;社会统一信用代码 证号为911100007109354688。 一、中化财务公司基本情况 (一)企业历史沿革、注册地、组织形式和总部地址 安徽荃银高科种业股份有限公司 关于中化集团财务有限责任公司 2023 年半年度风险评估报告 根据中国证券监督管理委员会、深圳证券交易所的相关要求,安徽荃银高科 种业股份有限公司(以下简称"本公司")通过查验中化集团财务有限责任公司 (以下简称"中化财务公司"或"公司")《金融许可证》《营业执照》等证件 资料,并审阅了中化财务公司验资及审计报告,对中化财务公司 ...
荃银高科(300087) - 荃银高科调研活动信息
2023-06-02 03:12
证券代码:300087 证券简称:荃银高科 安徽荃银高科种业股份有限公司投资者关系活动记录表 编号:2023-007 特定对象调研 □分析师会议 媒体采访 □业绩说明会 投资者关系活动 □新闻发布会 □路演活动 类别 现场参观 其他 参与单位名称及 中信证券 罗寅、黎刘定吉;仁桥资产 李远哲等 7 家机构 11 人员姓名 名参与人员。 时间 2023 年 5 月 31 日 上午 10:30-12:00 地点 公司 319 会议室 上市公司接待人 副董事长、总经理 张琴 员姓名 董事会秘书、财务总监 张庆一 1、请介绍公司基本情况。 安徽荃银高科种业股份有限公司是一家"以种业为核心、 农业服务为延伸、探索和创新农业多元化发展"的现代高科技 种业上市公司。2018 年 12 月中化现代农业有限公司成为公司 第一大股东,2021 年 12 月中化现代农业将持有的股权无偿划 转到中国种子集团有限公司。目前,公司为先正达种业板块的 投资者关系活动 重要成员,为国资委实控企业。 主要内容介绍 公司通过"内生"和"外延"双轮驱动,积极利用自有品 种、技术、品牌等优势,完善产业布局,提升种业市场份额, 增强整体竞争力;并充分 ...
荃银高科(300087) - 荃银高科调研活动信息
2023-05-22 08:17
证券代码:300087 证券简称:荃银高科 安徽荃银高科种业股份有限公司投资者关系活动记录表 编号:2023-006 特定对象调研 □分析师会议 媒体采访 □业绩说明会 □新闻发布会 □路演活动 投资者关系活动 现场参观 类别 其他 (深交所"踔厉奋发新征程 投教服务再出发 走进上市公司-荃银高科") 参与单位名称及 深圳证券交易所投服部、安徽证监局投保处、国元证券、华安 人员姓名 证券、安信证券及中小投资者代表共计 28 人。 时间 2023 年 5 月 18 日 下午 15:30-17:30 地点 公司 417 会议室 副董事长、总经理 张琴 上市公司接待人 副总经理 江三桥 员姓名 董事会秘书、财务总监 张庆一 本次投资者关系活动的主题为:深交所"踔厉奋进新征程 投教服务再出发"走进上市公司-荃银高科。 1、请介绍公司发展历程及基本情况。 安徽荃银高科种业股份有限公司是一家"以种业为核心、 农业服务为延伸、探索和创新农业多元化发展"的现代高科技 投资者关系活动 种业上市公司。2010 年 5 月公司在深交所创业板成功上市, 主要内容介绍 实现了从区域性水稻专业公司到集团化种业公司的转型。2018 年 1 ...
荃银高科(300087) - 2023 Q1 - 季度财报
2023-04-24 16:00
Financial Performance - The company's revenue for Q1 2023 was ¥617,457,763.96, representing a 40.22% increase compared to ¥440,361,052.90 in the same period last year[4] - Net profit attributable to shareholders for Q1 2023 was ¥31,317,074.01, a 53.40% increase from ¥20,415,502.56 year-on-year[4] - The net profit after deducting non-recurring gains and losses was ¥26,262,392.79, up 51.68% from ¥17,314,536.66 in the previous year[4] - The company achieved operating revenue of RMB 617.46 million in Q1 2023, representing a year-on-year increase of 40.22%[21] - Net profit for the period was RMB 37.59 million, up 25.88% compared to the same period last year[21] - Net profit attributable to shareholders of the listed company reached RMB 31.32 million, reflecting a significant growth of 53.40% year-on-year[21] - Net profit for Q1 2023 was CNY 37,588,549.11, representing a 25.5% increase from CNY 29,861,366.21 in Q1 2022[28] - Earnings per share (EPS) for Q1 2023 was CNY 0.0463, compared to CNY 0.0306 in the previous year, reflecting a growth of 51.8%[28] Cash Flow and Operating Activities - The company's cash flow from operating activities improved significantly, with a net cash flow of -¥13,460,206.30, an 88.78% improvement from -¥119,969,801.96 in Q1 2022[4] - Cash inflow from operating activities increased by 48.72% to ¥757,322,239.56, driven by higher sales receipts compared to ¥509,233,962.90 in Q1 2022[14] - Total cash inflow from operating activities amounted to ¥757,322,239.56, compared to ¥509,233,962.90 in the same period last year, representing an increase of approximately 48.7%[31] - Cash outflow from operating activities totaled ¥770,782,445.86, up from ¥629,203,764.86, indicating a year-over-year increase of about 22.5%[31] Assets and Liabilities - Total assets at the end of Q1 2023 were ¥4,582,810,388.56, a decrease of 9.75% from ¥5,078,108,520.77 at the end of the previous year[4] - The total assets decreased to CNY 4,582,810,388.56 from CNY 5,078,108,520.77, indicating a decline of 9.8%[26] - Total liabilities decreased to CNY 2,337,115,030.16 from CNY 2,885,034,817.02, a reduction of 19.0%[26] Shareholder Information - The total number of common stock shareholders at the end of the reporting period was 46,634[16] - The largest shareholder, China Seed Group Co., Ltd., holds 20.51% of the shares, totaling 138,781,447 shares[16] Inventory and Current Assets - The company reported a total of 1,168.83 million in inventory as of March 31, 2023[24] - The company’s total current assets amounted to RMB 3.14 billion, down from RMB 3.70 billion at the beginning of the year[24] Government Subsidies and Other Income - The company reported a significant increase in government subsidies, with other income rising to ¥7,902,012.48, a 538.44% increase from ¥1,237,702.28 year-on-year[12] Research and Development - The company has ongoing investments in research and development, with R&D expenses amounting to CNY 16,579,534.20, up from CNY 14,284,423.59 year-on-year[27] Financing Activities - The company experienced a substantial increase in financing activities, with cash inflow reaching ¥219,233,300.00, a 953.33% increase from ¥20,813,300.00 in the same period last year[14] - The net cash flow from financing activities was -¥116,480,127.11, compared to -¥2,761,251.28 in the same period last year[32] - Total cash inflow from financing activities was ¥219,233,300.00, a substantial increase from ¥20,813,300.00 in the previous year[32]
荃银高科:荃银高科业绩说明会、路演活动信息
2023-03-27 10:12
证券代码:300087 证券简称:荃银高科 安徽荃银高科种业股份有限公司投资者关系活动记录表 编号:2023-004 5、对未来 5 年国内种业格局有何判断。荃银有什么优势 和挑战? 您好!随着全球以"生物技术+信息化"为特征的种业科技 革命的兴起和我国农业现代化的加速推进,种业在农业发展中 的基础性、战略性、先导性、引领性地位日益突出。种企兼并 重组持续活跃,规模小、研发水平落后的企业逐步被淘汰或被 兼并,具备"育繁推一体化"经营能力的龙头企业迅速成长;优 质企业积极布局海外市场;种业与农化、信息、生产服务等领 域融合发展,逐步打造全产业链发展模式。 公司经过二十年 的育种研发实践与积累,已在科研人才、创新平台、科企合作、 资源与成果等方面形成了独特的竞争优势,为公司长期稳定发 展提供了坚实的科技支撑。充分发挥荃银品种的质量优势进行 营销模式创新,不断强化种子业务优势;此外,公司建立健全 中长期激励与约束机制,充分激发员工积极性。谢谢! 6、股价为什么跌 您好!股价由宏观经济、行业环境、公司基本面、资本市 场环境、资金面、投资者情绪等多重因素综合作用形成。公司 围绕战略目标,以科技创新为抓手,紧抓种业发展机 ...
荃银高科(300087) - 2022 Q4 - 年度财报
2023-03-17 16:00
Financial Performance - The company's operating revenue for 2022 was CNY 3,490,544,779.30, representing a 38.47% increase compared to CNY 2,520,772,778.56 in 2021[18]. - The net profit attributable to shareholders for 2022 was CNY 233,339,963.11, up 38.03% from CNY 169,045,332.23 in 2021[18]. - The net profit after deducting non-recurring gains and losses was CNY 176,222,836.31, a 17.82% increase from CNY 149,570,594.04 in 2021[18]. - The total assets at the end of 2022 reached CNY 5,078,108,520.77, a 43.51% increase from CNY 3,538,394,311.20 at the end of 2021[18]. - The net assets attributable to shareholders increased by 24.90% to CNY 1,715,399,430.57 from CNY 1,373,411,767.86 in 2021[18]. - The basic earnings per share for 2022 was CNY 0.35, reflecting a 34.62% increase from CNY 0.26 in 2021[18]. - The company reported a net cash flow from operating activities of CNY 397,602,337.65, down 8.69% from CNY 435,451,713.84 in 2021[18]. - The company achieved a revenue of 3,490.54 million yuan, representing a year-on-year growth of 38.47%[44]. - The net profit attributable to shareholders was 233.34 million yuan, an increase of 38.03% compared to the previous year[44]. - Agricultural revenue accounted for ¥3,409,168,118.41, which is 97.67% of total revenue, with a year-on-year growth of 37.28%[67]. Dividend and Profit Distribution - The company plans to distribute a cash dividend of 1 RMB per 10 shares to all shareholders based on a total share capital of 676,665,537 shares as of December 31, 2022[5]. - A cash dividend of RMB 1.00 per 10 shares (totaling RMB 67,666,553.70) was approved for distribution to shareholders[172]. - The company allocated 10% of its net profit, amounting to RMB 9,133,608.83, to statutory surplus reserves[171]. - The remaining distributable profit after dividends for 2022 is RMB 598,668,469.74[171]. - The company has no plans for stock dividends in the current profit distribution proposal[172]. Risk Management - The company faces risks including intensified market competition, new variety research and promotion risks, and changes in industrial policies, which are detailed in the management discussion section[4]. - The company has a comprehensive risk management strategy to address potential challenges in the seed industry[4]. - The company has faced risks related to seed production quality due to environmental factors and the management practices of contracted producers[37]. - The company acknowledges the risks associated with new variety development and production, emphasizing the need for market-oriented research and effective follow-up services[115]. - The company will strengthen its seed production bases to mitigate risks from climate change and natural disasters affecting seed quality and yield[115]. Research and Development - Research and development investments from 2020 to 2022 were 56.17 million, 83.28 million, and 113.85 million CNY respectively, indicating a consistent increase in R&D spending[33]. - The company has established a breeding system with a focus on independent research and collaboration with domestic research institutions, enhancing its innovation capabilities[34]. - The company has a research and development team of 244 people, accounting for 17.10% of the total workforce, ensuring strong innovation capabilities[45]. - The company is focused on developing high-yield and disease-resistant crop varieties, including hybrid rice and corn, to enhance agricultural innovation capabilities[76]. - The company is increasing R&D investment to enhance innovation capabilities and develop green high-quality new varieties to meet market demand[116]. Market Expansion and Sales - The company’s future outlook includes plans for market expansion and new product development, although specific figures are not disclosed in the report[4]. - The company is positioned in a growing industry with increasing government support for seed industry development and modernization[28]. - The company has a strong focus on international sales, with export plans developed annually based on customer needs, primarily using letters of credit for payment[38]. - The company is actively expanding its international presence, executing aid projects in countries like Sierra Leone, Togo, and Mali, and benefiting from the "Belt and Road" initiative[50]. - The company plans to achieve a revenue of 4 billion CNY and a net profit of 270 million CNY for 2023, although these targets are subject to market conditions and uncertainties[111]. Corporate Governance - The company emphasizes the importance of accurate financial reporting and has ensured that all board members attended the meeting to review the annual report[4]. - The company is committed to enhancing corporate governance and internal control systems to reduce risks and ensure sustainable development[121]. - The board of directors consists of 9 members, including 4 independent directors, ensuring compliance with legal and regulatory requirements[124]. - The supervisory board is composed of 3 members, including 1 employee representative, ensuring oversight of financial and operational compliance[125]. - The company maintains independent operations in business, personnel, assets, institutions, and finance, ensuring no reliance on the controlling shareholder, Zhongzhong Group[130]. Social Responsibility and Community Engagement - The company emphasizes social responsibility and stakeholder interests, aiming for a balanced approach to shareholder, customer, employee, and societal benefits[128]. - The company donated 2,000 kg of rice to frontline workers in Hefei during the pandemic[199]. - The company and its subsidiaries contributed over 2 million yuan to public welfare activities during the reporting period[199]. - The company established a platform for public welfare collaboration in Anhui to enhance regional cooperation and build a quality public welfare ecosystem[200]. Employee Engagement and Compensation - The company has implemented a stock incentive plan to align employee interests with corporate goals, enhancing motivation and performance[51]. - The employee stock ownership plan includes 284 employees holding a total of 8,227,400 shares, representing 1.22% of the company's total equity[174]. - The total remuneration paid to directors, supervisors, and senior management in 2022 amounted to CNY 8.8395 million[154]. - The company has established a salary management system, with board and supervisor remuneration decided by the shareholders' meeting and senior management remuneration based on performance assessment[165]. - The company organized various cultural and recreational activities to enhance employee cohesion and well-being, fostering a positive corporate culture[196].